Sis

GATA: a graphic alignment tool for comparative sequence analysis

Sometimes apotential target for a drug seems very promising on paper; things areoften very different in reality. Its the case of telomerase inhibitorsto treat cancer; they are supposed to strip the "immortal" (able todivide indefinitely) aspect of cancer cells. Yet, something in the cellseems to block their function, preventing them to inhibit completelythe...

Scientists find missing enzyme for tuberculosis iron scavenging pathway

Scientists have discovered that a protein that was originally believed to be involved in tuberculosis antibiotic resistance is actually a "missing enzyme" from the biosynthetic pathway for an agent used by the bacteria to scavenge iron. The research appears as the "Paper of the Week" in the April 8 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molec...

Antibiotic Resistant Bacterium Uses Sonar-like Strategy to “See?Enemies or Prey

For the first time, scientists have foundthat bacteria can use a Sonar-like system to spot other cells (eithernormal body cells or other bacteria) and target them for destruction.Reported in the December 24 issue of Science, this finding explains howsome bacteria know when to produce a toxin that makes infection moresevere. It may lead to the design of new toxin inhibitors. “Blocking orinte...

Study identifies predictors of HIV drug resistance in patients beginning triple therapy

A scientist at the Marine BiologicalLaboratory (MBL) has published the results of an EPA-funded clam embryostudy that supports her hypothesis that, when combined, the pollutantsbromoform, chloroform, and tetrachloroethylene--a chemical cocktailknown as BCE--can act synergistically to alter a key regulator in nervecell development. While scientists have previously studied the effectsof these...

Enzyme allows B cells to resist death, leading to leukemia

B cell chronic lymphocytic leukemia (B-CLL)is the most common leukemia in adults and is characterized by theprogressive accumulation of mature B lymphocytes in the blood, bonemarrow, and lymphatic tissues. It is believed that in the early stagesof disease, B-CLL is the result of an undefined defect in theprogrammed signals that trigger normal B cell death (apoptosis). LivioTrentin and colle...

NYC's First Rapid HIV Drug-resistant AIDS Case Prompts Call to Step Up HIV Prevention

New York City's Public Health Department today issued a public health advisory after reporting the first documented case of an alarming, new, rapidly-progressing and highly drug resistant strain of HIV in a New York man who progressed from his initial HIV infection, thought to have occurred in mid-October 2004, to a largely untreatable strain of AIDS in just three months. According to City...

Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications

The Institute of Bioengineering and Nanotechnology (IBN) has developed a novel method to simultaneously control the size and morphology of nanoparticles, which can be used in pharmaceutical synthesis and novel biomedical applications. This groundbreaking research was recently featured in the leading Chemistry journal, Angewandte Chemie, and a United States patent has been filed on the inv...

Kinovate Life Sciences Launches Nittophase?High Performance Solid Support For Oligonucleatide Synthesis

Kinovate Life Sciences, Inc, a provider of tools for oligonucleotide synthesis and gene delivery, announced today that it will officially launch its new NittoPhase?solid support for oligonucleotide synthesis at the TIDES meeting commencing in Boston on May 1st. The joint development of this solid phase support product was announced on November 8th, 2004 by Kinovate’s sole shareholder, Nitto Denko...

Potential treatments for neurofibromatosis

Neurofibromatosis can leave its patients miserable and debilitated with chronic itching or pain from disfiguring tumors. Infants affected by the disease face possible paralysis or damage to the brain and other organs. The disease frustrates doctors because there's no effective treatment even though the responsible gene was identified more than a decade ago. Currently little can be done to...

Drug-resistant bacteria on poultry products differ by brand

The presence of drug-resistant, pathogenic bacteria on uncooked poultry products varies by commercial brand and is likely related to antibiotic use in production, according to researchers at the Johns Hopkins Bloomberg School of Public Health. Their study is the first to directly compare bacterial contamination of poultry products sold in U.S. supermarkets from food producers who use antibiotics...

Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients

Multiple sclerosis (MS) can be an unpredictable disease. It develops when the body's immune system attacks healthy nerve cells and disrupts normal nerve signaling. Patients experience a wide range of symptoms—including tingling, paralysis, pain, fatigue, and blurred vision—that can appear independently or in combination, sporadically or persistently. Although symptoms appear in no particular orde...

Fibril Shape Is The Basis Of Prion Strains And Cross-species Prion Infection

New research on prions, the infectious proteins behind "mad cow" disease and Creutzfeld-Jakob disease in humans, suggests that the ability of prions in one species to infect other species depends on the shape of the toxic threadlike fibers produced by the prion. Two studies on the topic appear in the 8 April issue of the journal Cell. Although research suggests that prions from one specie...

Increased risk of osteoporosis associated with gene that one in five people have

About nineteen percent of people have a genetic variation that may increase susceptibility to osteoporosis, a new study reveals. Researchers at Washington University School of Medicine in St. Louis demonstrated that in women the variant gene speeds up the breakdown of estrogen and is associated with low density in the bones of the hip. The study will be reported in the February issue of t...

Multi-purpose protein regulates new protein synthesis and immune cell development

A signaling protein called IRE1, which helps stressed-out cells make new proteins, may be more versatile and important than scientists believed. A new study by researchers from the University of Michigan Medical School and the Howard Hughes Medical Institute reveals the surprising finding that this same signaling protein is required for the formation of immune cells called B lymphocytes....

Strongest proof yet found for prion hypothesis

UTMB scientists offer strongest evidence yet that infectious misformed proteins cause mad cow disease and other mysterious brain disorders Researchers at the University of Texas Medical Branch at Galveston (UTMB) have produced the strongest proof yet that the mysterious and devastating brain diseases known as "transmissible spongiform encephalopathies" (TSEs) are transmitted by an infecti...

Researchers make gains in understanding antibiotic resistance

Howard Hughes Medical Institute researchers chiseling away at the problem of antibiotic resistance now have a detailed explanation of how the drugs' main cellular target in bacteria evolves to become resistant to some of these medications. The findings are already leading to new experimental antibiotics that are being engineered to circumvent resistance, which is a major worldwide health problem....

Disease diagnosis, biodefense among UH chemical research projects

With 33 presentations of original research that showcase applications ranging from early-stage disease diagnosis to fuel cells and batteries, the University of Houston will be well represented at the 229th National Meeting of the American Chemical Society (ACS), March 13 to 17 in San Diego. Founded in 1876, the ACS is a nonprofit, scientific and educational organization and the largest sci...

Protein That Promotes Survival Of Stem Cells Might Be Key To Poor Leukemia Prognosis

The complex and life-sustaining series of steps by which hematopoietic stem cells (HSC) give rise to all of the body's red and white blood cells and platelets has now been discovered to depend in large part on a single protein called Mcl-1. This finding, from an investigator at St. Jude Children's Research Hospital, is published in the February 18 issue of Science. Mcl-1 blocks the biochem...

Discovery may lead to better Candidiasis drug

Oral biologists at the University at Buffalo have shown for the first time how histatin, the naturally occurring antifungal agent in saliva, kills the oral pathogen Candida albicans, the fungus responsible for most HIV-related oral infections. Researchers led by Mira Edgerton, D.D.S., Ph.D., discovered that histatin binds to a specific membrane protein called TRK1p, which regulates potass...

Global analysis of membrane proteins

All cells are encased within a protective lipid membrane. The membrane is studded with many hundreds of different proteins that transport nutrients, ions, and water into and out of the cell. Such membrane proteins also help cells recognize each other in the body, and make the nervous system work. Scientists at Stockholm University have now mapped out nearly all of the membrane proteins in the ent...

MUHC scientists describe genetic resistance to rampant virus

MUHC researchers have defined genetic resistance to the widespread virus, cytomegalovirus (CMV)--a member of the viral group that causes some of the world's most prevalent diseases, such as herpes, chicken pox and mononucleosis. The groundbreaking research published in Nature Genetics last week, provides a roadmap for the development of human therapies for CMV, which could prolong the life of HIV...

Virus-host interactions at sea effect global photosynthesis

Agilent Technologies Inc. (NYSE: A) today announced that it has for the first time released the chip design, probe sequence and annotation information for all of its microarrays. The release of this information is expected to improve cross-laboratory experimental research and cross-platform data comparison. "Full release of the probe sequences is an admirable and responsible position for A...

Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia

A new study is providing scientists with a better understanding of why some pediatric acute lymphoblastic leukemia (ALL) patients fail to respond to treatment even when existing clinical predictive criteria point towards a positive treatment outcome. The research, published in the April issue of Cancer Cell, is likely to facilitate development of new strategies to combat drug resistance and treat...

Doctors closer to using gene analysis to help trauma patients

A genetic tool with the potential to identify which trauma and burn patients are most likely to become seriously ill has worked consistently in a wide range of experimental clinical settings ?an important hurdle to overcome before the method is routinely used in emergency rooms and intensive care units. In a report published today (March 7) in the Proceedings of the National Academy of Sc...

Protein prevents detrimental immune effects of bacterial sepsis

The anti-inflammatory protein annexin 1 may protect patients from the detrimental effects of severe inflammatory response syndrome, as reported by researchers at Barts and the London, Queen Mary's School of Medicine and Dentistry. The paper by Damazo et al., "Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation," appears in the June issue of The Americ...

Basis for DNA ejection from single phage particles

Studying phage, a primitive class of virus that infects bacteria by injecting its genomic DNA into host cells, researchers have gained insight into the driving force behind this poorly understood injection process, which has been proposed in the past to occur through the release of pressure accumulated within the viral particle itself. Almost all phages (also known as bacteriophages) are f...

Agilent Technologies new genome analysis technology set to accelerate Australia fight against mesothelioma

Agilent Technologies Inc. (NYSE: A) today announced that its breakthrough Human Genome CGH Microarray technology will be used by researchers at Melbourne's Peter MacCallum Cancer Centre in a three-year study designed to better understand mesothelioma, a cancer found in the lining of the chest, the abdominal cavity and around the heart, usually caused by exposure to asbestos. Due to its act...

New polysaccharide may help combat multidrug resistance in cancer

In a recent study published in the Journal of Biological Chemistry, scientists report that a molecule previously thought to play a purely structural and inert role in cells is actually involved in multidrug resistance in cancer. Using antagonists for this molecule, the researchers were able to sensitize drug resistant breast cancer cells to chemotherapeutic drug treatment. The research ap...

Ariadne Genomics Announces the Release of PathwayStudio?Central, Client-Server Software for Biological Pathway Analysis

Ariadne Genomics, Inc. today announced the release of PathwayStudio?Central, client-server software for visualization and analysis of biological pathways and gene regulation networks for bio-medical research labs, biotechnology and pharmaceutical companies. PathwayStudio?Central is available for a free 20 day trial at www.ariadnegenomics.com. PathwayStudio?Central builds pathways from micr...

To Stop Evolution: New Way Of Fighting Antibiotic Resistance Demonstrated By Scripps Scientists

A team of scientists at The Scripps Research Institute and the University of Wisconsin have demonstrated a new way of fighting antibiotic resistance: by stopping evolution. In the June issue of the open-access journal PloS Biology, the team describes how a protein called LexA in the bacterium Escherichia coli promotes mutations and helps the pathogen evolve resistance to antibiotics. The...

Eliminate Data Analysis Bottlenecks in Drug Discovery

In the March 3 issue of Nature, Johns Hopkins researchers report that two proteins best known for very different activities actually come together to turn the liver into a sugar-producing factory when food is scarce. Because the liver's production of sugar is a damaging problem in people with diabetes, the proteins' interaction might be a target for future drugs to fight the disease, the research...

Owl genomics presents a HEPATOCHIP for diagnosis of non-alcoholic steatohepatitis

OWL Genomics, biotechnological company, has presented at the CIC bioGUNE hold at the Bizkaia Technological Park (Derio), the first DNA chip concerning diagnosis and prognosis of non-alcoholic steatohepatitis (NASH), allowing the discrimination between normal, steatosis and NASH predisposed subjects. Non alcoholic steatohepatitis is a progressive disease of the liver of unknown etiology, ch...

Analysis Of Human Genome To Predict The Development Of Illnesses

The GARBAN project, drawn up by Navarre University, will enable the identification of therapeutic targets for cancer, depression and hepatitis. The School of Engineering at Navarre University and its Centre for Technical Studies and Research in Gipuzkoa (CEIT) have launched an advanced biochemical analysis tool that will help in predicting the evolution of diseases, accelerate their diagno...

Chemical Engineer Kao Explores Antibiotic Synthesis With DNA Chips

Ask Assistant Professor of Chemical Engineering Camilla Kao to describe a bacterium, and she'll compare it to a factory capable of producing antibiotics, immunosuppressants and anti-cancer drugs that no chemist can synthesize. Bacteria normally produce antibiotics to inhibit other bacterial strains competing for resources. Pharmaceutical companies exploit this property to manufacture drugs, but t...

New book explains antibiotic resistance for a broad audience

Media coverage about "superbugs" that defy current treatments has increased the public's awareness of and fears surrounding the issue of antibiotic resistance. A new book from ASM Press, Revenge of the Microbes: How Bacterial Resistance is Undermining the Antibiotic Miracle, provides an in-depth overview of the subject in a reader-friendly, comprehensible style that will engage everyone from scie...

Evidence of 600-million-year old fungi-algae symbiosis discovered in marine fossils

Researchers from China and the United States have found evidence of lichen-like symbiosis in 600-million-year-old fossils from South China. The previous earliest evidence of lichen was 400 million years old, discovered in Scotland. The discovery also adds to the scarce fossil record of fungi and raises new questions about lichen evolution. Xunlai Yuan, a paleontologist with the Nanjing Ins...

New miniaturised chip dramatically reduces time taken for DNA analysis

A team of researchers at the Universitat Autònoma de Barcelona has developed new miniature sensors for analysing DNA. The sensors have the same size and thickness as a fingernail and reduce the time needed to identify DNA chains to several minutes or a few hours, depending on each chain. These sensors can be applied to many different tasks, ranging from paternity tests and identifying people to d...

Protein synthesis can be controlled by light, opening way for new scientific, medical applications

Proteins are the puzzle-pieces of life, involved in how organisms grow and flourish, but studying their complex biological processes in living systems has been extremely difficult. Now, a team of chemists and neurobiologists led by Timothy Dore at the University of Georgia and Erin M. Schuman at the California Institute of Technology has found a way to use light to regulate protein synthesis in s...

Researchers develop promising new gene network analysis method

Compared with a long-used linear model, a correlation-based statistical method is a more reliable way to map complex gene interactions and pinpoint genes that may be potential cancer treatment targets, according to new Brown University research. The research is important because it describes a promising new tool for tracing human gene connections, a task critical for understanding and tre...

Montreal researchers probe the genetic basis of memory

A group of Montreal researchers has discovered that GCN2, a protein in cells that inhibits the conversion of new information into long-term memory, may be a master regulator of the switch from short-term to long-term memory. Their paper Translational control of hippocampal synaptic plasticity and memory by the eIF2a kinase GCN2, which was published in the August 25th issue of the journal Nature,...